Definitive Healthcare Corp Stock Buy Hold or Sell Recommendation
| DH Stock | USD 2.59 0.16 5.82% |
Allowing for the 90-day total investment horizon and your above-average risk tolerance, our recommendation regarding Definitive Healthcare Corp is 'Hold'. The recommendation algorithm takes into account all of Definitive Healthcare's available fundamental, technical, and predictive indicators you will find on this site.
Check out Definitive Healthcare Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Definitive and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Definitive |
Execute Definitive Healthcare Buy or Sell Advice
The Definitive recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Definitive Healthcare Corp. Macroaxis does not own or have any residual interests in Definitive Healthcare Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Definitive Healthcare's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Definitive Healthcare Trading Alerts and Improvement Suggestions
| Definitive Healthcare generated a negative expected return over the last 90 days | |
| Definitive Healthcare has high historical volatility and very poor performance | |
| The company generated the yearly revenue of 252.2 M. Annual Net Loss to common stockholders was (591.45 M) with gross profit of 211.52 M. | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Acquisition by Winters Kathleen A of 26759 shares of Definitive Healthcare subject to Rule 16b-3 |
Definitive Healthcare Returns Distribution Density
The distribution of Definitive Healthcare's historical returns is an attempt to chart the uncertainty of Definitive Healthcare's future price movements. The chart of the probability distribution of Definitive Healthcare daily returns describes the distribution of returns around its average expected value. We use Definitive Healthcare Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Definitive Healthcare returns is essential to provide solid investment advice for Definitive Healthcare.
| Mean Return | -0.67 | Value At Risk | -5.82 | Potential Upside | 8.37 | Standard Deviation | 5.70 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Definitive Healthcare historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Definitive Stock Institutional Investors
| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 775.6 K | Millennium Management Llc | 2024-12-31 | 772.9 K | New York State Common Retirement Fund | 2024-12-31 | 771.8 K | D. E. Shaw & Co Lp | 2024-12-31 | 709.8 K | B. Riley Asset Management, Llc | 2024-12-31 | 677.9 K | Bank Of America Corp | 2024-12-31 | 617.5 K | Renaissance Technologies Corp | 2024-12-31 | 579.4 K | Citadel Advisors Llc | 2024-12-31 | 524.1 K | Northern Trust Corp | 2024-12-31 | 497.3 K | Advent International Lp | 2024-12-31 | 62.5 M | Irenic Capital Management Lp | 2024-12-31 | 7 M |
Definitive Healthcare Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | (23.9M) | (46.7M) | (248.9M) | (154.1M) | (26.4M) | (27.7M) | |
| Change In Cash | 16.2M | 362.7M | (240.6M) | (16.0M) | (25.6M) | (24.3M) | |
| Free Cash Flow | 21.8M | 18.5M | 27.3M | 38.2M | 58.2M | 33.7M | |
| Depreciation | 59.6M | 59.9M | 56.9M | 51.8M | 51.7M | 57.5M | |
| Other Non Cash Items | 13.7M | 20.7M | 13.1M | 192.2M | 705.4M | 740.7M | |
| Dividends Paid | 2.9M | 8.1M | 12.9M | 12.3M | 14.1M | 9.5M | |
| Capital Expenditures | 1.4M | 6.7M | 8.3M | 3.0M | 12.3M | 6.2M | |
| Net Income | (51.2M) | (61.3M) | (22.3M) | (202.4M) | (591.4M) | (561.9M) | |
| End Period Cash Flow | 24.8M | 387.5M | 146.9M | 131.0M | 105.4M | 147.4M |
Definitive Healthcare Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Definitive Healthcare or Health Care Technology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Definitive Healthcare's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Definitive stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.6 | |
β | Beta against Dow Jones | 0.58 | |
σ | Overall volatility | 5.94 | |
Ir | Information ratio | -0.09 |
Definitive Healthcare Volatility Alert
Definitive Healthcare Corp exhibits very low volatility with skewness of -3.02 and kurtosis of 18.62. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Definitive Healthcare's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Definitive Healthcare's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Definitive Healthcare Fundamentals Vs Peers
Comparing Definitive Healthcare's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Definitive Healthcare's direct or indirect competition across all of the common fundamentals between Definitive Healthcare and the related equities. This way, we can detect undervalued stocks with similar characteristics as Definitive Healthcare or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Definitive Healthcare's fundamental indicators could also be used in its relative valuation, which is a method of valuing Definitive Healthcare by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Definitive Healthcare to competition |
| Fundamentals | Definitive Healthcare | Peer Average |
| Return On Equity | -0.65 | -0.31 |
| Return On Asset | -0.0042 | -0.14 |
| Profit Margin | (1.64) % | (1.27) % |
| Operating Margin | 0.01 % | (5.51) % |
| Current Valuation | 255.39 M | 16.62 B |
| Shares Outstanding | 112.91 M | 571.82 M |
| Shares Owned By Insiders | 7.14 % | 10.09 % |
| Shares Owned By Institutions | 94.67 % | 39.21 % |
| Number Of Shares Shorted | 2.13 M | 4.71 M |
| Price To Book | 0.66 X | 9.51 X |
| Price To Sales | 1.16 X | 11.42 X |
| Revenue | 252.2 M | 9.43 B |
| Gross Profit | 211.52 M | 27.38 B |
| EBITDA | (567.24 M) | 3.9 B |
| Net Income | (591.45 M) | 570.98 M |
| Cash And Equivalents | 347.87 M | 2.7 B |
| Cash Per Share | 3.46 X | 5.01 X |
| Total Debt | 9.99 M | 5.32 B |
| Debt To Equity | 0.19 % | 48.70 % |
| Current Ratio | 3.32 X | 2.16 X |
| Book Value Per Share | 3.90 X | 1.93 K |
| Cash Flow From Operations | 58.2 M | 971.22 M |
| Short Ratio | 2.65 X | 4.00 X |
| Earnings Per Share | (3.54) X | 3.12 X |
| Price To Earnings To Growth | 1.03 X | 4.89 X |
| Target Price | 4.75 | |
| Number Of Employees | 782 | 18.84 K |
| Beta | 1.51 | -0.15 |
| Market Capitalization | 292.44 M | 19.03 B |
| Total Asset | 1.09 B | 29.47 B |
| Retained Earnings | (610 K) | 9.33 B |
| Working Capital | 209.01 M | 1.48 B |
| Net Asset | 1.09 B |
Note: Acquisition by Winters Kathleen A of 26759 shares of Definitive Healthcare subject to Rule 16b-3 [view details]
Definitive Healthcare Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Definitive . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Definitive Healthcare Buy or Sell Advice
When is the right time to buy or sell Definitive Healthcare Corp? Buying financial instruments such as Definitive Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Definitive Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cannabis Thematic Idea Now
Cannabis
Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally. The Cannabis theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cannabis Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Definitive Healthcare Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.54) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.